Table:
begin	end	state
1	36	cytoplasmic
37	55	transmembrane
56	64	non-cytoplasmic
65	84	transmembrane
85	93	cytoplasmic
94	113	transmembrane
114	118	non-cytoplasmic
119	141	transmembrane
142	162	cytoplasmic
163	186	transmembrane
187	197	non-cytoplasmic
198	216	transmembrane
217	244	cytoplasmic
245	263	transmembrane
264	281	non-cytoplasmic
282	302	transmembrane
303	310	cytoplasmic
311	330	transmembrane
331	335	non-cytoplasmic
336	360	transmembrane
361	371	cytoplasmic
372	393	transmembrane
394	404	non-cytoplasmic
405	423	transmembrane
424	435	cytoplasmic

Input:
>N515DRAFT_0011
MNSTTAGLIARAPAMTAGQRLRSIFSGSIGNLVEWYDWYVYSAFSLYFAQVFFPASDQTT
QLLNTSGIFAVGFLMRPLGGWLLGTFADRRGRKAALLLSVFMMSLGSLIIGLSPGYAQIG
VAAPILLVLARLLQGLSIGGEYGTSATYLSEMAPRESRGFWSSIQYVTLVAGQLIALALL
VVLQHFVLSTQQLHDWGWRIPFLIGALLAVIAVIIRRNMDETASFKKARQLESPLRTLMR
HPREVLTVIGLTMGGTLAFYTFTTYMQKFLVNSAGMSKADATSISTAALFVYALLQPAFG
ALSDRIGRRPLLIGFGVLGALLTYPILSTLKEAHDWWQAFGLIMAALIIVSGYTSINAVV
KAELFPTEIRAIGVGLPYALALSVFGGTAEYVALWFKKIGHEDYFYWYVTACIACSLLVY
IGMRDTRRHSRIVED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server